1. Home
  2. ICCC vs ECOR Comparison

ICCC vs ECOR Comparison

Compare ICCC & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.43

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$5.64

Market Cap

50.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
ECOR
Founded
1982
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
50.0M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
ICCC
ECOR
Price
$6.43
$5.64
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
12.2K
59.2K
Earning Date
03-04-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
65.33
N/A
EPS
0.20
N/A
Revenue
$26,493,169.00
$32,032,000.00
Revenue This Year
N/A
$34.03
Revenue Next Year
N/A
$30.42
P/E Ratio
$32.60
N/A
Revenue Growth
51.64
27.20
52 Week Low
$4.52
$4.16
52 Week High
$7.60
$8.55

Technical Indicators

Market Signals
Indicator
ICCC
ECOR
Relative Strength Index (RSI) 46.52 40.23
Support Level $6.20 $4.66
Resistance Level $6.79 $7.87
Average True Range (ATR) 0.18 0.62
MACD 0.01 -0.11
Stochastic Oscillator 39.26 9.14

Price Performance

Historical Comparison
ICCC
ECOR

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: